Cynosure Group’s Invesco QQQ Trust QQQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.3M Sell
19,341
-2,214
-10% -$1.58M 2.02% 14
2026
Q2
$15.9M Sell
21,555
-20,858
-49% -$14.4M 2.39% 13
2026
Q1
$24.5M Buy
42,413
+29,348
+225% +$17.8M 3.06% 9
2025
Q4
$8.03M Sell
13,065
-32,352
-71% -$19.9M 0.82% 22
2025
Q3
$27.3M Buy
45,417
+3,712
+9% +$2.13M 2.96% 7
2025
Q2
$23M Buy
41,705
+26,676
+177% +$13.3M 2.61% 8
2025
Q1
$7.05M Sell
15,029
-19,842
-57% -$10.1M 0.97% 21
2024
Q4
$17.8M Buy
34,871
+5,921
+20% +$2.99M 2.66% 10
2024
Q3
$14.1M Buy
28,950
+5,773
+25% +$2.73M 2.06% 12
2024
Q2
$11.1M Buy
23,177
+14,966
+182% +$6.73M 1.78% 12
2024
Q1
$3.65M Sell
8,211
-12,973
-61% -$5.56M 0.65% 24
2023
Q4
$8.68M Buy
21,184
+3,410
+19% +$1.29M 1.56% 11
2023
Q3
$6.37M Buy
17,774
+4
+0% +$1.48K 1.95% 13
2023
Q2
$6.56M Buy
+17,770
New +$5.98M 1.97% 15
2020
Q2
– Sell
-9,071
Closed -$1.73M – 53
2020
Q1
$1.73M Buy
+9,071
New +$1.92M 1.24% 19

Other funds holding QQQ

Cynosure Group's QQQ Position: Q3 2026 in Review

Cynosure Group reduced its Invesco QQQ Trust (QQQ) stake by 10% in Q3 2026, selling an estimated $1.58M and leaving 19,341 shares worth $14.3M. The position accounts for 2.02% of the portfolio, ranked #14.

Cynosure Group first reported a position in QQQ in Q1 2020 and has held it in 15 quarters since. The position peaked at $27.3M in Q3 2025. 3,616 funds tracked by Wall St. Rank hold QQQ as of Q3 2026.

  • Cynosure Group held 19,341 shares of Invesco QQQ Trust worth $14.3M as of Q3 2026.
  • Cynosure Group sold 2,214 Invesco QQQ Trust shares in Q3 2026, an estimated $1.58M.
  • Invesco QQQ Trust made up 2.02% of Cynosure Group's portfolio in Q3 2026, its #14 holding.
  • Cynosure Group first reported a position in Invesco QQQ Trust in Q1 2020 and has held it in 15 quarters since.
  • Cynosure Group's Invesco QQQ Trust position peaked at $27.3M in Q3 2025.
  • 3,616 funds tracked by Wall St. Rank held Invesco QQQ Trust as of Q3 2026.

Based on Cynosure Group's 13F filing for Q3 2026, filed 3 Nov 2026.